𝔖 Bobbio Scriptorium

✦ LIBER ✦

98 O - Tamoxifen +/- short-term chemotherapy in the treatment of node positive, hormone receptor positive breast cancer: 7-year results of a randomized trial including 517 patients

✍ Scribed by R. Jakesz; H. Hausmaninger; H. Samonigg; E. Kubista; M. Gnant; G. Steger

Book ID: 116168376
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 187 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(96)84855-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy versus tamoxifen versus che

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial

✍ Boccardo, F.; Rubagotti, A.; Amoroso, D.; Sismondi, P.; Genta, F.; Nenci, I.; Pi 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Zoledronic acid prevents bone mineral de

Zoledronic acid prevents bone mineral density loss in premenopausal women receiving adjuvant treatment for hormone receptor-positive breast cancer: Preliminary results of a randomized, multicenter trial of zoledronic acid in patients receiving anastrozole or tamoxifen in combination with goserelin

✍ H. Hausmaninger 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 184 KB